Ripple Therapeutics Corp.
$810,564.00 CAD
≈ 10 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- January 1, 2022 – January 31, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q4-986775
Published purpose
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. Scientific and engineering resources will perform work on the development of Ripple’s lead product IBE-814 IVT for the treatment of Diabetic Macular Edema and Retinal Vein Occlusion. The project will require analysis of data generated from the ongoing clinical trial, and development and scale up of the product for the next stages on the path to commercialization.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions